Join the Community Online
with the European Society for Paediatric Infectious Diseases

In this time of uncertainty, we still believe in the communal importance of the ESPID Annual Meeting and its ability to bring together international infectious diseases experts, thousands of clinicians, researchers, residents, and students. Further, we are looking to transform this COVID crisis into a new opportunity, one that will open a wide and ongoing discussion on our collective local and national experiences and challenges, with positive effects reaching beyond the meeting. Therefore, we have decided to transform ESPID 2020 into a fully virtual meeting.

See you there. Online!

PRESENT YOUR RESEARCH IN 2020

Late Breaking Abstracts Extended Deadline: 15 July

SUBMIT ABSTRACT

NEW AND REDUCED PARTICIPATION RATES

Members EUR150 | Students/Nurses EUR50 (other rates start from EUR200)

REGISTER

Virtual #ESPID2020: What to Expect

  • Watch all the sessions you are interested in – live or recorded
  • Earn the maximum CME credits by visiting all relevant lectures
  • Browse the research presentations and e-posters, and discuss them with their authors
  • Ask your questions and interact live with the PID experts, international colleagues, and industry representatives
  • And so much more!

AS A BONUS: All sessions will be available on demand, to registered participants, for up to 3 months following the Virtual Meeting.

VIRTUAL MEETING FAQ

VIRTUAL MEETING FAQ

Click here

PROGRAMME

PROGRAMME

Click here

LATE BREAKING RESEARCH

LATE BREAKING RESEARCH

Click here

SUPPORT & EXHIBITION

SUPPORT & EXHIBITION

Click here

Don't Miss An Update

Subscribe to our newsletter to get all the Meeting updates

ESPID 2019 In Numbers

agreed that the Meeting improved their professional performance and will make changes to their practice

would recommend the ESPID Meeting to others

agreed that ESPID enhances opportunities for future collaboration between groups of young researchers

agreed that ESPID indicated the latest developments and challenges about vaccines

would attend an ESPID Meeting again